2020
DOI: 10.1021/acs.langmuir.0c02109
|View full text |Cite
|
Sign up to set email alerts
|

Novel Type of Water-Soluble Photosensitizer from Trichoderma reesei for Photodynamic Inactivation of Gram-Positive Bacteria

Abstract: sorbicillinoids obtained by microbial fermentation using T. reesei. Sorbicillinoids could effectively generate singlet oxygen under UV light irradiation, and ultimately display photoinactivation activity on Gram-positive bacteria, but not Gram-negative ones. More importantly, UV light can generally only be used to inactivate bacteria on the surface due to its weak penetration. However, it can penetrate deep into the solution and inactivate bacteria in the presence of sorbicillinoids. Therefore, sorbicillinoids… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
25
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 13 publications
(26 citation statements)
references
References 67 publications
1
25
0
Order By: Relevance
“…Moreover, selective killing of bacteria can be readily achieved in the presence of mammalian cells. Br-DAPI’s sub-micromolar potency in both gram-negative and gram-positive bacteria make it superior to commonly employed phenothiazinium PSs like the FDA approved MB as demonstrated here, and to other recently reported PSs, which in addition to having lower potencies, often photoinactivate either gram-positive or gram-negative bacteria, but not both 10,16,35,36 . Given its high potency, bacterial selectivity over mammalian cells, and 2-photon excitability, Br-DAPI may be a promising stand-alone PS for treating more complex bacterial systems.…”
Section: Discussionmentioning
confidence: 50%
See 4 more Smart Citations
“…Moreover, selective killing of bacteria can be readily achieved in the presence of mammalian cells. Br-DAPI’s sub-micromolar potency in both gram-negative and gram-positive bacteria make it superior to commonly employed phenothiazinium PSs like the FDA approved MB as demonstrated here, and to other recently reported PSs, which in addition to having lower potencies, often photoinactivate either gram-positive or gram-negative bacteria, but not both 10,16,35,36 . Given its high potency, bacterial selectivity over mammalian cells, and 2-photon excitability, Br-DAPI may be a promising stand-alone PS for treating more complex bacterial systems.…”
Section: Discussionmentioning
confidence: 50%
“…In contrast, bacteria treated with Br-DAPI and light reduced total genomic DNA of N99 E. Coli and B. subtilis by 74% and 73%, respectively (Figure 5). The lack of appearance of new bands at lower molecular weights is assumed to be due to ROS induced double-stranded DNA breaks, which lead to fragments at concentrations too low to detect by staining, as observed in previously reported PS photocleavage experiments 10, 22 . Overall, these experiments confirm that at least one molecular target of Br-DAPI is DNA, which may be one contributor to the observed high potency in gram-negative and gram-positive bacteria.…”
Section: Resultsmentioning
confidence: 57%
See 3 more Smart Citations